180 related articles for article (PubMed ID: 30423986)
21. Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2013 Aug; 34(4):2109-17. PubMed ID: 23580180
[TBL] [Abstract][Full Text] [Related]
22. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer.
Donnem T; Al-Shibli K; Andersen S; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Sep; 116(18):4318-25. PubMed ID: 20549821
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
24. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
25. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
27. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.
Fan F; Wey JS; McCarty MF; Belcheva A; Liu W; Bauer TW; Somcio RJ; Wu Y; Hooper A; Hicklin DJ; Ellis LM
Oncogene; 2005 Apr; 24(16):2647-53. PubMed ID: 15735759
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
Grummer MA; Sullivan JA; Magness RR; Bird IM
Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
[TBL] [Abstract][Full Text] [Related]
31. Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients.
Bernatz S; Monden D; Gessler F; Radic T; Hattingen E; Senft C; Seifert V; Ronellenfitsch MW; Plate KH; Harter PN; Baumgarten P
J Mol Histol; 2021 Apr; 52(2):233-243. PubMed ID: 33528717
[TBL] [Abstract][Full Text] [Related]
32. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
[TBL] [Abstract][Full Text] [Related]
33. [Vascular endothelial growth factor and two types of its receptors in breast cancer].
Shcherbakov AM; Gershteĭn ES; Anurova OA; Kushlinskiĭ NE
Vopr Onkol; 2005; 51(3):317-21. PubMed ID: 16279095
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
Ustuner Z; Saip P; Yasasever V; Vural B; Yazar A; Bal C; Ozturk B; Ozbek U; Topuz E
Med Oncol; 2008; 25(4):394-9. PubMed ID: 18317954
[TBL] [Abstract][Full Text] [Related]
36. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract][Full Text] [Related]
37. High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.
Ghosh S; Sullivan CA; Zerkowski MP; Molinaro AM; Rimm DL; Camp RL; Chung GG
Hum Pathol; 2008 Dec; 39(12):1835-43. PubMed ID: 18715621
[TBL] [Abstract][Full Text] [Related]
38. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
[TBL] [Abstract][Full Text] [Related]
39. Microvessel density and VEGF/VEGF receptor status and their role in sarcomas of the pulmonary artery.
Gaumann AK; Schermutzki G; Mentzel T; Kirkpatrick CJ; Kriegsmann JB; Konerding MA
Oncol Rep; 2008 Feb; 19(2):309-18. PubMed ID: 18202776
[TBL] [Abstract][Full Text] [Related]
40. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer.
Bando H; Weich HA; Brokelmann M; Horiguchi S; Funata N; Ogawa T; Toi M
Br J Cancer; 2005 Feb; 92(3):553-61. PubMed ID: 15668703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
